Companion Diagnostic TestsOncology and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Companion Diagnostic Tests in Oncology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Companion Diagnostic Tests in Oncology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Companion Diagnostic Tests in Oncology Overall Market Size
2.1 Global Companion Diagnostic Tests in Oncology Market Size: 2023 VS 2030
2.2 Global Companion Diagnostic Tests in Oncology Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Companion Diagnostic Tests in Oncology Players in Global Market
3.2 Top Global Companion Diagnostic Tests in Oncology Companies Ranked by Revenue
3.3 Global Companion Diagnostic Tests in Oncology Revenue by Companies
3.4 Top 3 and Top 5 Companion Diagnostic Tests in Oncology Companies in Global Market, by Revenue in 2023
3.5 Global Companies Companion Diagnostic Tests in Oncology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Companion Diagnostic Tests in Oncology Players in Global Market
3.6.1 List of Global Tier 1 Companion Diagnostic Tests in Oncology Companies
3.6.2 List of Global Tier 2 and Tier 3 Companion Diagnostic Tests in Oncology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Companion Diagnostic Tests in Oncology Market Size Markets, 2023 & 2030
4.1.2 Protein Detection
4.1.3 DNA Detection
4.2 By Type - Global Companion Diagnostic Tests in Oncology Revenue & Forecasts
4.2.1 By Type - Global Companion Diagnostic Tests in Oncology Revenue, 2019-2024
4.2.2 By Type - Global Companion Diagnostic Tests in Oncology Revenue, 2025-2030
4.2.3 By Type - Global Companion Diagnostic Tests in Oncology Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Companion Diagnostic Tests in Oncology Market Size, 2023 & 2030
5.1.2 Pharmaceutical & Biotechnology Companies
5.1.3 Medical Device Companies
5.1.4 Research Institutes
5.1.5 Others
5.2 By Application - Global Companion Diagnostic Tests in Oncology Revenue & Forecasts
5.2.1 By Application - Global Companion Diagnostic Tests in Oncology Revenue, 2019-2024
5.2.2 By Application - Global Companion Diagnostic Tests in Oncology Revenue, 2025-2030
5.2.3 By Application - Global Companion Diagnostic Tests in Oncology Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Companion Diagnostic Tests in Oncology Market Size, 2023 & 2030
6.2 By Region - Global Companion Diagnostic Tests in Oncology Revenue & Forecasts
6.2.1 By Region - Global Companion Diagnostic Tests in Oncology Revenue, 2019-2024
6.2.2 By Region - Global Companion Diagnostic Tests in Oncology Revenue, 2025-2030
6.2.3 By Region - Global Companion Diagnostic Tests in Oncology Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Companion Diagnostic Tests in Oncology Revenue, 2019-2030
6.3.2 US Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.3.3 Canada Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.3.4 Mexico Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Companion Diagnostic Tests in Oncology Revenue, 2019-2030
6.4.2 Germany Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.4.3 France Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.4.4 U.K. Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.4.5 Italy Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.4.6 Russia Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.4.7 Nordic Countries Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.4.8 Benelux Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Companion Diagnostic Tests in Oncology Revenue, 2019-2030
6.5.2 China Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.5.3 Japan Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.5.4 South Korea Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.5.5 Southeast Asia Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.5.6 India Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Companion Diagnostic Tests in Oncology Revenue, 2019-2030
6.6.2 Brazil Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.6.3 Argentina Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Companion Diagnostic Tests in Oncology Revenue, 2019-2030
6.7.2 Turkey Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.7.3 Israel Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.7.4 Saudi Arabia Companion Diagnostic Tests in Oncology Market Size, 2019-2030
6.7.5 UAE Companion Diagnostic Tests in Oncology Market Size, 2019-2030
7 Companion Diagnostic Tests in Oncology Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Companion Diagnostic Tests in Oncology Major Product Offerings
7.1.4 Abbott Companion Diagnostic Tests in Oncology Revenue in Global Market (2019-2024)
7.1.5 Abbott Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Companion Diagnostic Tests in Oncology Major Product Offerings
7.2.4 Roche Companion Diagnostic Tests in Oncology Revenue in Global Market (2019-2024)
7.2.5 Roche Key News & Latest Developments
7.3 Genomic Health
7.3.1 Genomic Health Company Summary
7.3.2 Genomic Health Business Overview
7.3.3 Genomic Health Companion Diagnostic Tests in Oncology Major Product Offerings
7.3.4 Genomic Health Companion Diagnostic Tests in Oncology Revenue in Global Market (2019-2024)
7.3.5 Genomic Health Key News & Latest Developments
7.4 QIAGEN
7.4.1 QIAGEN Company Summary
7.4.2 QIAGEN Business Overview
7.4.3 QIAGEN Companion Diagnostic Tests in Oncology Major Product Offerings
7.4.4 QIAGEN Companion Diagnostic Tests in Oncology Revenue in Global Market (2019-2024)
7.4.5 QIAGEN Key News & Latest Developments
7.5 Agilent
7.5.1 Agilent Company Summary
7.5.2 Agilent Business Overview
7.5.3 Agilent Companion Diagnostic Tests in Oncology Major Product Offerings
7.5.4 Agilent Companion Diagnostic Tests in Oncology Revenue in Global Market (2019-2024)
7.5.5 Agilent Key News & Latest Developments
7.6 Agendia
7.6.1 Agendia Company Summary
7.6.2 Agendia Business Overview
7.6.3 Agendia Companion Diagnostic Tests in Oncology Major Product Offerings
7.6.4 Agendia Companion Diagnostic Tests in Oncology Revenue in Global Market (2019-2024)
7.6.5 Agendia Key News & Latest Developments
7.7 BioMerieux
7.7.1 BioMerieux Company Summary
7.7.2 BioMerieux Business Overview
7.7.3 BioMerieux Companion Diagnostic Tests in Oncology Major Product Offerings
7.7.4 BioMerieux Companion Diagnostic Tests in Oncology Revenue in Global Market (2019-2024)
7.7.5 BioMerieux Key News & Latest Developments
7.8 Illumina
7.8.1 Illumina Company Summary
7.8.2 Illumina Business Overview
7.8.3 Illumina Companion Diagnostic Tests in Oncology Major Product Offerings
7.8.4 Illumina Companion Diagnostic Tests in Oncology Revenue in Global Market (2019-2024)
7.8.5 Illumina Key News & Latest Developments
7.9 Siemens Healthcare
7.9.1 Siemens Healthcare Company Summary
7.9.2 Siemens Healthcare Business Overview
7.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Major Product Offerings
7.9.4 Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue in Global Market (2019-2024)
7.9.5 Siemens Healthcare Key News & Latest Developments
7.10 Thermo Fisher
7.10.1 Thermo Fisher Company Summary
7.10.2 Thermo Fisher Business Overview
7.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Major Product Offerings
7.10.4 Thermo Fisher Companion Diagnostic Tests in Oncology Revenue in Global Market (2019-2024)
7.10.5 Thermo Fisher Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Companion Diagnostic Tests in Oncology Market Opportunities & Trends in Global Market
Table 2. Companion Diagnostic Tests in Oncology Market Drivers in Global Market
Table 3. Companion Diagnostic Tests in Oncology Market Restraints in Global Market
Table 4. Key Players of Companion Diagnostic Tests in Oncology in Global Market
Table 5. Top Companion Diagnostic Tests in Oncology Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Companion Diagnostic Tests in Oncology Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Companion Diagnostic Tests in Oncology Revenue Share by Companies, 2019-2024
Table 8. Global Companies Companion Diagnostic Tests in Oncology Product Type
Table 9. List of Global Tier 1 Companion Diagnostic Tests in Oncology Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Companion Diagnostic Tests in Oncology Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Companion Diagnostic Tests in Oncology Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Companion Diagnostic Tests in Oncology Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Companion Diagnostic Tests in Oncology Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Companion Diagnostic Tests in Oncology Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Companion Diagnostic Tests in Oncology Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Companion Diagnostic Tests in Oncology Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2025-2030
Table 30. Abbott Company Summary
Table 31. Abbott Companion Diagnostic Tests in Oncology Product Offerings
Table 32. Abbott Companion Diagnostic Tests in Oncology Revenue (US$, Mn) & (2019-2024)
Table 33. Abbott Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Companion Diagnostic Tests in Oncology Product Offerings
Table 36. Roche Companion Diagnostic Tests in Oncology Revenue (US$, Mn) & (2019-2024)
Table 37. Roche Key News & Latest Developments
Table 38. Genomic Health Company Summary
Table 39. Genomic Health Companion Diagnostic Tests in Oncology Product Offerings
Table 40. Genomic Health Companion Diagnostic Tests in Oncology Revenue (US$, Mn) & (2019-2024)
Table 41. Genomic Health Key News & Latest Developments
Table 42. QIAGEN Company Summary
Table 43. QIAGEN Companion Diagnostic Tests in Oncology Product Offerings
Table 44. QIAGEN Companion Diagnostic Tests in Oncology Revenue (US$, Mn) & (2019-2024)
Table 45. QIAGEN Key News & Latest Developments
Table 46. Agilent Company Summary
Table 47. Agilent Companion Diagnostic Tests in Oncology Product Offerings
Table 48. Agilent Companion Diagnostic Tests in Oncology Revenue (US$, Mn) & (2019-2024)
Table 49. Agilent Key News & Latest Developments
Table 50. Agendia Company Summary
Table 51. Agendia Companion Diagnostic Tests in Oncology Product Offerings
Table 52. Agendia Companion Diagnostic Tests in Oncology Revenue (US$, Mn) & (2019-2024)
Table 53. Agendia Key News & Latest Developments
Table 54. BioMerieux Company Summary
Table 55. BioMerieux Companion Diagnostic Tests in Oncology Product Offerings
Table 56. BioMerieux Companion Diagnostic Tests in Oncology Revenue (US$, Mn) & (2019-2024)
Table 57. BioMerieux Key News & Latest Developments
Table 58. Illumina Company Summary
Table 59. Illumina Companion Diagnostic Tests in Oncology Product Offerings
Table 60. Illumina Companion Diagnostic Tests in Oncology Revenue (US$, Mn) & (2019-2024)
Table 61. Illumina Key News & Latest Developments
Table 62. Siemens Healthcare Company Summary
Table 63. Siemens Healthcare Companion Diagnostic Tests in Oncology Product Offerings
Table 64. Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue (US$, Mn) & (2019-2024)
Table 65. Siemens Healthcare Key News & Latest Developments
Table 66. Thermo Fisher Company Summary
Table 67. Thermo Fisher Companion Diagnostic Tests in Oncology Product Offerings
Table 68. Thermo Fisher Companion Diagnostic Tests in Oncology Revenue (US$, Mn) & (2019-2024)
Table 69. Thermo Fisher Key News & Latest Developments
List of Figures
Figure 1. Companion Diagnostic Tests in Oncology Segment by Type in 2023
Figure 2. Companion Diagnostic Tests in Oncology Segment by Application in 2023
Figure 3. Global Companion Diagnostic Tests in Oncology Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Companion Diagnostic Tests in Oncology Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Companion Diagnostic Tests in Oncology Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Companion Diagnostic Tests in Oncology Revenue in 2023
Figure 8. By Type - Global Companion Diagnostic Tests in Oncology Revenue Market Share, 2019-2030
Figure 9. By Application - Global Companion Diagnostic Tests in Oncology Revenue Market Share, 2019-2030
Figure 10. By Type - Global Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Companion Diagnostic Tests in Oncology Revenue Market Share, 2019-2030
Figure 12. By Application - Global Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Companion Diagnostic Tests in Oncology Revenue Market Share, 2019-2030
Figure 14. By Region - Global Companion Diagnostic Tests in Oncology Revenue Market Share, 2019-2030
Figure 15. By Country - North America Companion Diagnostic Tests in Oncology Revenue Market Share, 2019-2030
Figure 16. US Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Companion Diagnostic Tests in Oncology Revenue Market Share, 2019-2030
Figure 20. Germany Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 21. France Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Companion Diagnostic Tests in Oncology Revenue Market Share, 2019-2030
Figure 28. China Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 32. India Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Companion Diagnostic Tests in Oncology Revenue Market Share, 2019-2030
Figure 34. Brazil Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Companion Diagnostic Tests in Oncology Revenue Market Share, 2019-2030
Figure 37. Turkey Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Companion Diagnostic Tests in Oncology Revenue, (US$, Mn), 2019-2030
Figure 41. Abbott Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Roche Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Genomic Health Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. QIAGEN Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Agilent Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Agendia Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. BioMerieux Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Illumina Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Thermo Fisher Companion Diagnostic Tests in Oncology Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
